Industry News
First results from the largest international comparison of the treatment of elderly patients with breast cancer have shown there are substantial differences in the use of surgery, hormone therapy...
Millions of people are dying from potentially treatable cancers like breast and prostate because of a chronic underinvestment in radiotherapy resources, according to a major new Commission on...
Childhood cancers in Europe: progress has been made, but much remains to be done, says major report
9/26/2015
Each year in Europe, 6,000 young people die from cancer, and two-thirds of those who survive suffer from treatment-related side effects.
Control of immune cells could mean safer, more precise cancer treatment
9/26/2015
Scientists have found ways to control the action of CAR T cells for the treatment of cancer. The use of medication enables the cells to be switched 'on' at the right moment.
EUROCARE results show large variations in survival from blood cancers between European countries
9/26/2015
New analysis also shows lower survival from all cancers in Denmark, the UK and Eastern Europe than in neighbouring countriesComparisons of cancer patients' survival and care in Europe up to...
Primary surgery is associated with survival benefit in patients with advanced cancers of the throat
9/25/2015
Patients with cancers of the mid- and lower throat may have higher survival rates if their initial treatment includes surgery, according to new research presented to the 2015 European Cancer...
Patients with advanced kidney cancer live for nearly twice as long without their disease progressing if they are treated with cabozantinib, a drug that inhibits the action of tyrosine kinases ...
The targeted drug nivolumab significantly prolongs survival in patients with advanced kidney cancer, whose disease has progressed after their first treatment, according to results to be presented...
Why are many women at risk of ovarian cancer not aware of it?
9/25/2015
The color teal in September represents Ovarian Cancer Awareness Month. This may be the most difficult women's cancer to detect and treat, yet many women are unaware of the risks.
'Remote control' of immune cells opens door to safer, more precise cancer therapies
9/25/2015
UC San Francisco researchers have engineered a molecular "on switch" that allows tight control over the actions of T cells, immune system cells that have shown great potential as therapies for...